• Quoin Pharmaceuticals held its annual general meeting on Aug. 20, 2026.
• Shareholders backed changes to the company’s non-employee director compensation program.
• Investors also authorized changes to matching contributions under the company’s 401(k) plan, including for U.S.-based executive officers.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Quoin Pharmaceuticals Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-099239), on August 20, 2026, and is solely responsible for the information contained therein.